Table 3 (A) Treatment related adverse events (AEs) according to the Clavien-Dindo classification TURP patients, (B) Treatment related adverse events (AEs) according to the Clavien-Dindo classification HoLEP patients.

From: Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer

A

Adverse events (AEs)

 

TURP (n = 42)

pTURP (n = 42)

p value

Overall AEs; n (%)

4 (9.5%)

7 (16.7%)

0.521

Clavien Dindo I

0

0

 

Urinary retention

   

Clavien Dindo II

1 (2.4%)

2 (4.8%)

1.0

Clot retention

1

1

 

Clavien Dindo III

3 (7.1%)

5 (11.9%)

0.713

Urinary retention

0

1

 

Clot retention

2

1

 

Bleeding

1

3

 

B

Adverse events (AEs)

 

HoLEP (n = 48)

pHoLEP (n = 48)

p value

Overall AEs; n (%)

4 (8.3%)

6 (12.5%)

0.74

Clavien Dindo I

0

0

 

Urinary retention

   

Clavien Dindo II

0

1 (2.1%)

1.0

Clot retention

0

1

 

Clavien Dindo III

4 (8.3%)

5 (10.4%)

1.0

Urinary retention

1

1

 

Clot retention

2

1

 

Bleeding

1

2

 

Urethral stricture

0

1

 
  1. Bold values indicate statistically significant p values (p < 0.05)
Back to article page